Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib(488 views) Marotta V, Di Somma C, Rubino M, Sciammarella C, Modica R, Camera L, Del Prete M, Marciello F, Ramundo V, Circelli L, Buonomano P, Colao A, Faggiano A
Keywords: Sorafenib, Sunitinib, Adult, Adverse Outcome, Case Report, Clinical Feature, Diarrhea, Differentiated Thyroid Cancer, Drug Substitution, Drug Treatment Failure, Drug Withdrawal, Female, Hand Foot Syndrome, Human, Letter, Lung Metastasis, Lymph Node Metastasis, Middle Aged, Outcome Assessment, Priority Journal, Progression Free Survival, Treatment Response, Tumor Necrosis, Tumor Volume,
Affiliations: *** IBB - CNR ***
Department of Clinical Medicine and Surgery, Section of Endocrinology, Federico II University of Naples, Via S. Pansini 5, Naples, Italy
IRCCS SDN, Naples, Italy
Department of Advanced Biomedical Sciences, Federico II University of Naples, Naples, Italy
National Cancer Institute, “Fondazione G. Pascale”, Naples, Italy
References: Not available.
Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib
Not available.
Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib
No results.
Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib
Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP, Valzania F, Fagioli G, Distefano A, Bagnato A, Feggi L, Anna S, Maria Teresa Rosaria De Cr, Nobili F, Mazzuca N, Baldari S, Eleopra R, Bestetti A, Benti R, Varrone A, Volterrani D, Massa R, Stocchi F, Schillaci O, Dore F, Zibetti M, Castellano G, Battista SG, Giorgetti G * The relationship between cerebral vascular disease and parkinsonism: The VADO study(775 views) Parkinsonism Relat D (ISSN: 1353-8020, 1873-5126, 1873-5126electronic), 2012; 18(6): 775-780. Impact Factor:3.274 ViewExport to BibTeXExport to EndNote